Prevalence of Pneumocystis Jiroveci pneumonia in Tunisian primary immunodeficient patients;Prévalence de la pneumopathie à Pneumocystis Jiroveci au cours des déficits immunitaires héréditaires observés en Tunisie

Archives de Pediatrie

Volumn 14, Issue 1, 2007, Pages 20-23

  BenMustapha Darghouth, I ^a   Trabelsi, S ^a   Largueche, B ^a   Bejaoui, M ^b   Dellagi, K ^a   Barbouche, M R ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

Author keywords

Child; Pneumocystis carinii pneumonia; Severe combined immunodeficiency

Indexed keywords

HLA ANTIGEN CLASS 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMBINED IMMUNODEFICIENCY; CONSANGUINEOUS MARRIAGE; HUMAN; HUMORAL IMMUNITY; HYPERIMMUNOGLOBULINEMIA M; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LUNG LAVAGE; MAJOR CLINICAL STUDY; NORTH AFRICA; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; RETROSPECTIVE STUDY; T LYMPHOCYTE; TUNISIA; FEMALE; INFANT; MALE; NEWBORN; PREVALENCE;

FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; MALE; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; PREVALENCE; RETROSPECTIVE STUDIES; TUNISIA;

EID: 33845991836     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.10.012     Document Type: Article

References (30)

1. Bartlett M.S., and Smith J.W. Pneumocystis Carinii, an opportunist in immunocompromised patients. Clin. Microbiol. Rev. 4 (1991) 137-149
2. Phair J., Munoz A., Ditels R., et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N. Engl. J. Med. 322 (1990) 161-165
3. Sepkowitz K.A. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin. Infect. Dis. 34 (2002) 1098-1107
4. Berrington J.E., Flood T.J., Abinun M., et al. Unsuspected Pneumocystis carinii Pneumonia at presentation of severe primary immunodeficiency. Arch. Dis. Child 82 (2000) 144-147
5. Baumgartner R., Durant P.J., van Gessel Y., et al. Evidence for the requirement of T cell costimulation in the pathogenesis of natural Pneumocystis carinii pulmonary infection. Microb Pathog 33 (2002) 193-201
6. Winkelstein J.A., Marino M.C., Ochs H., et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine 82 (2003) 373-384
7. Alibrahim A., Lepore M., Lierl M., et al. Pneumocystis carinii pneumonia in an infant with X-linked agammaglobulinemia. J. Allergy Clin. Immunol. 101 (1998) 552-553
8. Smart J.M., Kemp A.S., and Armstrong D.S. Pneumocystis Carinii pneumonia in an infant with transient hypogammaglobulinemia of infancy. Arch. Dis. Child. 87 (2002) 449-450
9. Kallel K., Belhadj S., Zribi A., et al. La pneumocystose : maladie peu fréquente en Tunisie ?. Med. Mal. Infect. 28 (1998) 311-312
10. Abouya Y.L., Beaumel A., Lucas S., et al. Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Am. Rev. Respir. Dis. 145 (1992) 617-620
11. Damoua K., N'Dhatz M., Coulibaly G., et al. Complications pulmonaires de l'infection à VIH dans l'Afrique subsahélienne. Rev. Pneumol. Clin. 53 (1997) 79-84
12. M'Boussa J., Kaoudi E., Kobolo J., et al. Faible dissémination du parasite en Afrique. Pneumocystose observées au Congo chez les malades atteints de SIDA. Rev. Pneumol. Clin. 47 (1991) 39-42
13. Béjaoui M., Barbouche M.R., Mellouli F., et al. Déficit immunitaire primitif par défaut d'expression des antigènes HLA de classe II : neuf observations tunisiennes. Arch. Pediatr. 5 (1998) 1089-1093
14. Ben Rachid M.S., Khaled S., Tiouiri H., et al. La pneumocystose pulmonaire en Tunisie. À propos de 6 cas. Tunis. Med. 72 (1994) 446-449
15. Ennaifer-Jerbi E., Louzir B., Huerre M., et al. Fréquence des pneumopathies à Pneumocystis carinii chez le sujet infecté par VIH en Tunisie. Tunis. Med. 80 (2002) 29-32
16. Russian D.A., and Kovacs J.A. Pneumocystis carinii in Africa: an emerging pathogen?. Lancet 346 (1995) 1242-1243
17. Smulian A.G., Sullivan D., Linke M.J., et al. Geographic variation in the humoral response to Pneumocystis carinii. J. Infect. Dis. 167 (1993) 1243-1247
18. Klein C., Lisowska-Grospierre B., LeDeist F., et al. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J. Pediatr. 123 (1993) 921-928
19. Béjaoui M., Barbouche M.R., Sassi A., et al. Les déficits immunitaires primitifs en Tunisie : étude de 152 cas. Arch. Pediatr. 4 (1997) 827-831
20. Villard J., Masternak K., Lisowska-Grospierre B., et al. MHC class II deficiency: a disease of gene regulation. Medicine (Baltimore) 80 (2001) 405-418
21. Krawczyk M., and Reith W. Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. Tissue Antigens 67 (2006) 183-197
22. Béjaoui M., Mellouli F., Chouanine R., et al. Le syndrome d'hyper-IgM: 13 observations. Presse Med. 32 (2003) 544-549
23. Beck J.M., and Harmsen A.G. Lymphocytes in host defense against Pneumocystis carinii. Semin. Respir. Infect. 13 (1998) 330-338
24. Limper A.H., Hoyte J.S., and Standing J.E. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Invest. 99 (1997) 2110-2117
25. Walzer P.D. Immunological features of Pneumocystis carinii infection in humans. Clin. Diagn. Lab. Immunol. 6 (1999) 149-155
26. Thomas Jr. C.F., and Limper A.H. Pneumocystis pneumonia. N. Engl. J. Med. 350 (2004) 2487-2498
27. Garvy B.A., Ezekowitz R.A., and Harmsen A.G. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect. Immun. 65 (1997) 373-379
28. Hughes W.T. Pneumocystis carinii Pneumonia. Semin. Pediatr. Infect. Dis. 12 (2001) 309-314
29. Dei-Cas E. Infections à Pneumocystis carinii : biologie. Encycl med chir, Maladies infectieuses, 8-590-A-10,1996,3 p.
30. Hennequin C. Prophylaxie des infections parasitaires (toxoplasmose exclue) chez les patients immunodéprimés. Ann. Med. Intern. 148 (1997) 240-245